Genpact LTD·4

Feb 21, 4:11 PM ET

Stein Kathryn Vanpelt 4

4 · Genpact LTD · Filed Feb 21, 2023

Insider Transaction Report

Form 4
Period: 2023-02-16
Stein Kathryn Vanpelt
Senior Vice President
Transactions
  • Sale

    Common Shares

    2023-02-16$47.29/sh45,000$2,128,11876,706 total
  • Sale

    Common Shares

    2023-02-16$47.30/sh10,500$496,62166,206 total
  • Exercise/Conversion

    Common Shares

    2023-02-16$27.70/sh+45,000$1,246,500121,706 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2023-02-1645,000123,101 total
    Exercise: $27.70Exp: 2029-01-09Common Shares (45,000 underlying)
Footnotes (3)
  • [F1]The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.00 to $47.59. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F2]The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $47.02 to $47.57. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F3]The option vested 50% on January 10, 2022 and will vest 50% on January 10, 2024, subject to the reporting person's continued service through such date.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4